Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats

Pancreas

Volumn 20, Issue 4, 2000, Pages 348-360

  Anini, Younès ^a   Jarrousse, Claire ^b   Chariot, Jacques ^a   Nagain, Claire ^a   Yanaihara, Noboru ^d   Sasaki, Kazuyuki ^e   Bernad, Nicole ^c   Le Nguyen, Dung ^b   Bataille, Dominique ^b   Rozé, Claude ^a  

^a INSERM   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c CNRS   (France)

^d Yanaihara Institute Inc   (Japan)

^e NISSHIN SEIFUN GROUP INC   (Japan)

Author keywords

Cholecystokinin; Glicentin; GLP 1; Oxyntomodulin; Oxyntomodulin 19 37; Pancreatic secretion; Peptide YY

Indexed keywords

ACETYLCHOLINE; CHOLECYSTOKININ OCTAPEPTIDE; DEOXYGLUCOSE; GLICENTIN; OXYNTOMODULIN; PEPTIDE YY;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ELECTROSTIMULATION; MALE; NERVOUS SYSTEM; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; DEOXYGLUCOSE; DRUG INTERACTIONS; GLICENTIN; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; KINETICS; MALE; OXYNTOMODULIN; PANCREAS; PEPTIDE FRAGMENTS; PEPTIDE YY; PROTEIN PRECURSORS; RATS; RATS, WISTAR; SINCALIDE; VAGUS NERVE;

EID: 17444450664     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200005000-00003     Document Type: Article

References (43)

1. Dumoulin V, Dakka T, Plaisancie P, Chayvialle JA, Cuber JC. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. Endocrinology 1995; 136:5182-8.
2. Anini Y, Fu-Cheng X, Cuber JC, Kervran A, Chariot J, Rozé C. Comparison of the postprandial release of peptide YY and proglucagon derived peptides in the rat. Pflugers Arch 1999;438:299-306.
3. Bataille D, Coudray AM, Carlqvist M, Rosselin G, Mutt V. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejunoileum: isolation of the peptide. FEBS Lett 1982;146:73-8.
4. Thim L, Moody AJ. The primary structure of porcine glicentin (proglucagon). Regul Pept 1981;2:139-50.
5. Jarrousse C, Carles-Bonnet C, Niel H, et al. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat. Am J Physiol 1993;264:G816-23.
6. Kirkegaard P, Moody AJ, Holst JJ, Loud FB, Olsen PS, Christiansen J. Glicentin inhibits gastric acid secretion in the rat. Nature 1982;297:156-7.
7. Jarrousse C, Carles-Bonnet C, Niel H, Bataille D. Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat. Peptides 1994;15:1415-20.
8. Schjoldager B, Mortensen PE, Christensen J, Orskov C, Holst JJ. GLP-1 (glucagon-like peptide-1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in man. Dig Dis Sci 1989;35:703-8.
9. Biedzinski TM, Bataille D, Devaux MA, Sarles H. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat. Peptides 1987;8:967-72.
10. Beauclair F, Eto B, Pansu D, et al. Oxyntomodulin reduces hydromineral transport through rat small intestine. Dig Dis Sci 1998; 43:1814-23.
11. Taylor IL. Role of peptide YY in the endocrine control of digestion. J Dairy Sci 1993;76:2094-101.
12. Putnam WS, Liddle RA, Williams JA. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am J Physiol 1989;256:G698-703.
13. Guan D, Maouyo D, Taylor IL, Gettys TW, Greeley GH Jr, Morisset J, Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. Endocrinology 1991;128:911-6.
14. Jin H, Cai L, Lee K, Chang TM, Li P, Wanger D, Chey WY. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology 1993;105:208-15.
15. Nagain C, Chariot J, Rozé C. Differential effect of peptide YY, neuropeptide Y, and sigma ligands on neurally stimulated external pancreatic secretion in the rat. Pancreas 1995;10:123-30.
16. Grandt D, Siewert J, Sieburg B, et al. Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors. Pancreas 1995;10:180-6.
17. Carles-Bonnet C, Jarrousse C, Niel H, Martinez J, Bataille D. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat. Eur J Pharmacol 1991;203:245-52.
18. Gros L, Thorens B, Bataille D, Kervran A. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology 1993;133:631-8.
19. Gros L, Hollande F, Thorens B, Kervran A, Bataille D. Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function. Eur J Pharmacol 1995;288: 319-27.
20. Kervran A, Dubrasquet M, Blache P, Martinez J, Bataille D. Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney. Regul Pept 1990;31:41-52.
21. Bado A, Cloarec D, Moizo L, Laigneau JP, Bataille D, Lewin MJ. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions. Am J Physiol 1993; 265:0113-7.
22. Rozé C, de la Tour J, Chariot J, Souchard M, Vaille C, Debray C. Pancreatic stimulation induced by 2-deoxy-D-glucose in rats: analysis of nervous and humoral mechanisms. Gastroenterol Clin Biol 1977;1:435-46.
23. Rozé C, La Tour J, Chariot J, Souchard M, Debray C. Technique détude de la sécrétion pancréatique externe chez le rat. Biol Gastroenterol 1975;8:291-5.
24. Chariot J, Rozé C. Détermination automatisée de trés faibles concentrations de bicarbonates: application au suc pancréatique. Ann Biol Clin 1976;34:269-72.
25. Nagain C, Mendre C, Rodriguez M, Bernard C, Martinez J, Rozé C. External pancreatic secretion in the rat: supramaximal inhibition induced by the cholecystokinin octapeptide [CCK(26-33)] and analogs altered on the 28-29 bond. Peptides 1989;10:1041-7.
26. Chariot J, Rozé C, De la Tour J, Vaille C. Vagal non-cholinergic stimulation of external pancreatic secretion in rats. Gastroenterol Clin Biol 1982;6:371-8.
27. Jensen RT, Lemp GF, Gardner JD. Interactions of carboxy-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea-pig pancreas. J Biol Chem 1982;257:5554-9.
28. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine: optimal conditions. Clin Chim Acta 1969;26:437-44.
29. Le Quellec A, Kervran A, Blache P, Ciurana AJ, Bataille D. Oxyntomodulin-like immunoreactivity: diurnal profile of a new potential enterogastrone. J Clin Endocrinol Metab 1992;74:1405-9.
30. Rodier G, Magous R, Mochizuki T, et al. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells. Pflugers Arch 1997;434:729-34.
31. Audousset-Puech MP, Dufour M, Kervran A, et al. Solid-phase peptide synthesis of human (Nle-27)-oxyntomodulin: preliminary evaluation of its biological activities. FEBS Lett 1986;200:181-5.
32. Fu-Cheng X, Anini Y, Chariot J, Castex N, Galmiche JP, Rozé C. Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflugers Arch 1997;433:571-9.
33. Souli A, Fu-Cheng X, Chariot J, Tsocas A, Rozé C. Antisecretory effects of YY peptide and neuropeptide Y at three levels of the small intestine in rats. Gastroenterol Clin Biol 1996;20:8-14.
34. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christensen J, Holst JJ, Truncated GLP-1 (proglucagon 72-107 amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993;38:665-73.
35. Holst JJ, Rasmussen TN, Harling H, Schmidt P. Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas. Pancreas 1993;8:80-7.
36. Wettergren A, Wojdemann M, Holst JJ. Glucagon-like peptide-1 inhibits gastropancreatic function by central parasympathetic outflow. Am J Physiol 1998;275:G984-92.
37. Li Y, Zhu JX, Rillamas E, Nozu F, Owyang C. Glucagon-like-peptide-1 acts via dorsal complex to inhibit pancreatic enzyme secretion. Gastroenterology 1998;114:A1158.
38. Herzig KH, Louie DS, Tatemoto K, Owyang C. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. Am J Physiol 1992;262:G113-7.
39. Li Y, Owyang C. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 1993;92:418-24.
40. Miyasaka K, Funakoshi A, Yasunami Y, et al. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats. Regul Pept 1990;28:189-98.
41. Miyasaka K, Funakoshi A, Kitani K, Tamamura H, Funakoshi S, Fujii N. Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Gastroenterology 1990;99:1751-6.
42. Pappas TN, Debas HT, Taylor IL. Enterogastrone-like effect of peptide YY is vagally mediated in the dog. J Clin Invest 1986;77: 49-53.
43. Jung G, Louie DS, Owyang C. Pancreatic polypeptide inhibits pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 1987;253:0706-10.